title: Interdigitating dendritic cell sarcoma of the leg.
authors.forename: Zdenek
authors.initials: Z
authors.lastname: Adam
authors.forename: Ludek
authors.initials: L
authors.lastname: Pour
authors.forename: Karel
authors.initials: K
authors.lastname: Veselý
authors.forename: Marta
authors.initials: M
authors.lastname: Krejcí
authors.forename: Frantisek
authors.initials: F
authors.lastname: Fakan
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Hofstädter
authors.forename: Tomás
authors.initials: T
authors.lastname: Büchler
authors.forename: Roman
authors.initials: R
authors.lastname: Hajek
authors.forename: Jirí
authors.initials: J
authors.lastname: Mayer
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D054739:Dendritic Cell Sarcoma, Interdigitating / Q000188:drug therapy* / Q000473:pathology*; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007866:Leg / Q000473:pathology*; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone